Ernexa Therapeutics Inc. (ERNA) Live Share Price, Invest From India

Ernexa Therapeutics Inc. Stock Performance

as on August 6, 2026 at 2:15 pm IST

Day's Low
Day's High
$3.86
Day's Price Range
$4.68
$4.10
5.85%
Downside
14.15%
Upside
52 Week's Low
52 Week's High
$3.18
52-Week Price Range
$71.50
$4.10
22.37%
Downside
1643.84%
Upside

Ernexa Therapeutics Inc. share price movements today

Previous Close: $4.42
Open: $4.61
Volume: 306.7K
Day's Low - High: $3.86 - $4.68
52 Week Low - High: $3.18 - $71.50

Ernexa Therapeutics Inc. Historical Returns

1 Month Return: -36.34 %
3 Month Return: -32.12 %
1 Year Return: -90.24 %
3 Year Return: -99.62 %
5 Year Return: 0 %

Ernexa Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Ernexa Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.8M

EPS (TTM)

-18.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-10.1M

Revenue (TTM)

1.0K

Profit Margin

0.00%

Return On Equity TTM

-2505.61%

Ernexa Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ernexa Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Ernexa Therapeutics Inc.	SELL	$4.8M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$41.1B	605.15%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$121.3B	141.61%	27.93	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$78.3B	25.82%	18.8	27.87%	0.48%

Stock Returns calculator for Ernexa Therapeutics Inc. Stock including INR - Dollar returns

The Ernexa Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Ernexa Therapeutics Inc. investment value today

Current value as on today

₹10,581

Returns

-₹89,419

(-89.42%)

Returns from Ernexa Therapeutics Inc. Stock

-₹90,238 (-90.24%)

Dollar Impact

₹819 (+0.82%)

Analyst Recommendation on Ernexa Therapeutics Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Ernexa Therapeutics Inc.. Average target price of $30

Ernexa Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Ernexa Therapeutics Inc..

What analysts predicted

86.33%UPSIDE

Target Price

$30

Current Price

$4.1

Analyzed by

6 Analysts

Target

$30.00

Ernexa Therapeutics Inc. target price $30, a slight upside of 86.33% compared to current price of $4.1. According to 6 analysts rating.

Indian Investors' Interest in Ernexa Therapeutics Inc. Stock

Search interest for Ernexa Therapeutics Inc. Stock has increased by 439% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 7, 2026 to August 6, 2026

Change:439% versus previous 30 day period

Ernexa Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	0	0
Operating Income	-5	-5	-4	-2	-2	-2	-2	-1	-2	-3
EBITDA	-5	-5	-4	-24	-2	-8	-3	-1	-6	-5
Interest Expense	0	0	0	1	3	0	-	0	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-6	-5	-26	-5	-8	-3	-1	-1	-5
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-6	-6	-5	-26	-5	-8	-3	-1	-1	-5
Net Profit Margin	-36194.12%	-14142.55%	-11763.83%	-5462.83%	-575900.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Ernexa Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	22	21	23	19	5	-	-	0	0	-
Gross Profit	14	14	14	11	0	0	0	0	0	0
Operating Income	-2	-1	0	-1	-7	-113	-33	-21	-15	-9
EBITDA	0	0	3	1	-26	-121	-24	-19	-36	-13
Interest Expense	0	0	0	0	0	0	0	0	6	0
Depreciation	-	-	-	-	0	0	0	0	1	0
Income Before Tax	-2	-1	0	-2	-26	-122	-24	-21	-44	-14
Income Tax Expense	0	0	0	0	-19	0	0	0	0	0
Net Income	-2	-1	0	-2	11	-122	-24	-21	-44	-14
Net Profit Margin	-13.10%	-5.06%	-1.11%	-10.34%	205.28%	0.00%	0.00%	-31864.71%	-7652.75%	0.00%

Ernexa Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-6	-5	-26	-5	-8	-3	-1	-1	-5
Operating Cash Flow	-3	-2	-6	-3	-2	-2	-1	-1	-2
Investing Cash Flow	0	0	0	-	-	-	0	0	0
Financing Cash Flow	1	0	3	1	2	4	0	-7	9
Change in Cash	-2	-2	1	-2	0	2	-1	-1	7

Ernexa Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	0	-2	-26	-122	-24	-21	-44	-14
Operating Cash Flow	0	1	2	-8	-23	-20	-20	-15	-7
Investing Cash Flow	-1	-1	-1	0	-22	0	0	0	0
Financing Cash Flow	-1	0	-1	4	61	19	16	6	7
Change in Cash	-2	0	0	-1	15	-1	-3	-9	0

Global Institutional Holdings in Ernexa Therapeutics Inc.

Funds	Holdings
Bank of America Corp	0%
CI Private Wealth LLC	3%
Vanguard Capital Management, LLC	0.09%
Susquehanna International Group, LLP	0%
BNP Paribas Arbitrage, SA	0%

See all

Insights on Ernexa Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ERNA stock has moved up by 18.2%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 438.0% return, outperforming this stock by 528.2%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 532.2% return, outperforming this stock by 631.8%

About Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Organisation	Ernexa Therapeutics Inc.
Headquarters	1035 Cambridge Street, Cambridge, MA, United States, 02141
Industry	Biotechnology
CEO	Mr. Sanjeev Luther
E-voting on shares	Click here to vote

Key Management of Ernexa Therapeutics Inc.

Name	Title
Mr. Sanjeev Luther	CEO, President & Director
Dr. Robert Hamilton Pierce M.D.	Chief Scientific Officer
Ms. Dorothy J. Clarke	General Counsel
Dr. Kanika Chawla Ph.D.	Senior Vice President of Technical Operations (Consultant)

FAQs

What is Ernexa Therapeutics Inc. share price today?

Ernexa Therapeutics Inc. share price today is $4.10 as on August 6, 2026 at 8:45 am IST at the close of the market. Ernexa Therapeutics Inc. share today touched a day high of $4.68 and a low of $3.86.

What is the 52 week high and 52 week low for Ernexa Therapeutics Inc. share?

Ernexa Therapeutics Inc. share touched a 52 week high of $71.50 on October 29, 2025 and a 52 week low of $3.18 on May 4, 2026. Ernexa Therapeutics Inc. stock price today i.e. August 6, 2026 at 8:45 am IST is closed at $4.10,which is 94.27% down from its 52 week high and 28.81% up from its 52 week low.

What is Ernexa Therapeutics Inc.'s market capitalisation today?

Ernexa Therapeutics Inc. market capitalisation is $0.00T as on August 6, 2026 at 8:45 am IST.

How to invest in Ernexa Therapeutics Inc. Stock (ERNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ernexa Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ernexa Therapeutics Inc. Shares that will get you 0.3659 shares as per Ernexa Therapeutics Inc. share price of $4.10 per share as on August 6, 2026 at 8:45 am IST.

What is the minimum amount required to buy Ernexa Therapeutics Inc. Stock (ERNA) from India?

Indian investors can start investing in Ernexa Therapeutics Inc. (ERNA) shares with as little as ₹95.2 or $1 (as of August 6, 2026 at 6:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Ernexa Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on August 6, 2026 at 6:38 pm IST). Based on Ernexa Therapeutics Inc. share’s latest price of $4.10 as on August 6, 2026 at 8:45 am IST, you will get 2.4390 shares of Ernexa Therapeutics Inc.. Learn more about fractional shares .